83 results on '"Buza, Elizabeth"'
Search Results
52. MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates
53. Adeno‐associated virus serotype 1‐based gene therapy for FTD caused by GRN mutations
54. Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology
55. A rational mouse model to detect on-target, off-tumor CAR T cell toxicity
56. The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
57. Supplemental_material - Agreement in Histological Assessment of Mitotic Activity Between Microscopy and Digital Whole Slide Images Informs Conversion for Clinical Diagnosis
58. A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease
59. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
60. Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivogenome editing of PCSK9
61. Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene
62. Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma
63. Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma
64. Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
65. Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression
66. IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus Infection
67. Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice
68. Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
69. Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene.
70. Abstract 3187: Depleting cells expressing fibroblast activation protein disrupts tumor-promoting desmoplasia
71. Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells
72. The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection
73. Malignant peripheral nerve sheath tumor in a cat with nodal and pulmonary metastases
74. CT FEATURES OF PLEURAL MASSES AND NODULES
75. Assessing the Safety of Cytotoxic T Lymphocytes Transduced With a Dominant Negative Transforming Growth Factor-β Receptor
76. The Use of Autologous LMP2-Specific Cytotoxic T Lymphocytes (CTL) for the Treatment of Relapsed EBV-Positive Hodgkin Disease and Non-Hodgkin Lymphoma.
77. The Clinical Use of Donor-Derived Virus-Specific Cytotoxic T Lymphocytes Reactive Against Cytomegalovirus (CMV), Adenovirus and Epstein Barr Virus (EBV).
78. Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-Positive Nasopharyngeal Carcinoma and Lymphoma
79. CT FEATURES OF PLEURAL MASSES AND NODULES.
80. 795. The Use of Autologous LMP2-Specific Cytotoxic T Lymphocytes for the Treatment of Relapsed EBV +ve Hodgkin Disease and Non-Hodgkin Lymphoma
81. 1074. The Use of Genetically Modified Antigen Presenting Cells to Generate Donor-Derived Virus-Specific Cytotoxic T Lymphocytes Reactive Against CMV and Adenoviral Antigens for Clinical Use
82. Erratum: Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors.
83. Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.